The quantitation of hepatitis C virus (HCV) viremia RNA is measured by molecular techniques such as comcan be helpful in the diagnosis, therapy, and monitoring petitive reverse-transcription polymerase chain reacof patients with chronic hepatitis C. A sensitive and tion and branched DNA (bDNA) signa
Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATs
✍ Scribed by Krister Melén; Riku Fagerlund; Maria Nyqvist; Päivi Keskinen; Ilkka Julkunen
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 557 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
IFN‐α combined with ribavirin is used for the treatment of chronic hepatitis C. However, HCV has mechanisms to resist the antiviral actions of IFN‐α. In order to study the molecular mechanisms of this resistance, the effect of HCV gene expression on IFN‐induced nuclear import of STAT transcription factors and the expression of antiviral MxA protein were studied. In transiently transfected hepatoma cells, HCV core and NS5A proteins clearly inhibited the nuclear import of STAT1 and MxA protein expression (core only), whereas other viral proteins had only a marginal effect. To confirm these observations, human osteosarcoma‐derived cell lines, which inducibly express HCV core protein, the entire structural region (core‐E1‐E2‐p7), the NS3‐4A complex, NS4B, NS5A, or NS5B proteins were also used. IFN‐induced nuclear accumulation of STAT1 was almost completely and STAT2 was partially blocked in cell lines expressing high levels of HCV core protein. Subsequently, in these cells, IFN‐α‐induced MxB protein expression was decreased. Tumor necrosis factor‐α (TNF‐α)‐induced nuclear import of NF‐κB was only weakly or not at all inhibited, suggesting that the nuclear import machinery in general was not impaired. The results demonstrate a novel mechanism by which HCV gene expression may interfere with IFN‐mediated host defence systems. J. Med. Virol. 73:536–547, 2004. © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Hepatitis C virus (HCV) infection is an important cause of chronic liver disease. Standard therapy, pegylated interferon ␣ (pegIFN␣) combined with ribavirin, results in a sustained response rate in approximately half of patients. The cause of treatment failure in the other half of the patients is un
Hepatitis C virus (HCV) remains a major medical problem. Antiviral treatment is only partially effective and a vaccine does not exist. Development of more effective therapies has been hampered by the lack of a suitable small animal model. Although xenotransplantation of immunodeficient mice with hum
The hepatitis C virus (HCV) core protein is involved in viral pathogenesis such as oxidative stress induction and lipid metabolism disturbance, and is primarily located in the cytoplasm and endoplasmic reticulum in association with lipid droplets as well as in the mitochondria. To clarify the impact
The cellular localization of the precore/core and core proteins was studied by immunofluorescence following transfection of 143 thymidine kinase-negative (TK ) and Hep-G2 cells with expression constructs containing wild-type (hepatitis B e antigen [HBeAg]-positive) and precore mutant (HBeAg-negative